JNJ vs KO: Which Is the Better Buy?
Side-by-side comparison of Johnson & Johnson and The Coca-Cola Company — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-06-20.
Johnson & Johnson · Healthcare
$228.39
-20.6% upside to fair value
Grade D
High Quality
VS
The Coca-Cola Company · Consumer Defensive
$79.39
-9.9% upside to fair value
Grade D
High Quality
QuantHub Verdict
KO has more upside to fair value
(-9.9%).
KO trades at a lower forward P/E
(24.9x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
JNJ |
KO |
| Current Price |
$228.39 |
$79.39 |
| Fair Value Estimate |
$181.44 |
$71.54 |
| Upside to Fair Value |
-20.6%
|
-9.9%
|
| Market Cap |
$549.8B |
$341.6B |
| Forward P/E |
26.3x
|
24.9x
|
| EV / EBITDA |
17.4x
|
19.5x
|
| Price / Sales |
5.7x
|
6.9x
|
| Price / FCF |
30.9x
|
27.2x
|
| Revenue Growth YoY |
+9.9%
|
+12.1%
|
| Gross Margin |
69.1%
|
61.7%
|
| Operating Margin |
26.9%
|
29.3%
|
| Return on Equity |
26.3%
|
43.6%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
3.24%
|
3.68%
|
| Analyst Consensus |
Buy
|
Strong Buy
|
Investment Thesis
Johnson & Johnson is a leading global healthcare company focused on innovative medicine and MedTech following the Kenvue consumer spin-off. It benefits from a durable competitive moat with strong market positions in pharmaceuticals and medical devices, supported by a long-tenured management team and disciplined capital allocation. However, the stock is currently very expensive, trading approximat…
The Coca-Cola Company is a leading global branded beverages company with a very wide moat in sparkling soft drinks and non-alcoholic ready-to-drink beverages. It benefits from strong pricing power, stable margins, and high recurring cash flow, supported by a seasoned management team with deep company tenure. Despite solid recent growth with revenue up 12.1% and earnings up 17.8% in the most recen…
Accumulation Zones
| Metric |
JNJ |
KO |
| Zone Low |
$136.08 |
$53.66 |
| Zone High |
$154.22 |
$60.81 |
| In Buy Zone? |
No
|
No
|